Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

Harry P. Erba, Richard F. Schlenk, Po‐Nan Wang et al.|The Lancet|2023

Cited by 387